Insider filing
Traded Aug 10 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
DMAC · NASDAQ · Pharmaceutical Preparations
Diamedica Therapeutics (DMAC) · oqro.io/stocks/DMAC · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$8.25+0.23 (+2.87%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Including 15 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Aug 10 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 2 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 2 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 2 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Nov 17 – Nov 25, 2025 · largest single transaction ~$1.73M
Nov 19, 2025~$1.73M · 240K sh @ $7.21
DetailsOfficial recordTraded Nov 21, 2025 · largest single transaction ~$26K
Nov 21, 202512K · @ $2.20
DetailsOfficial recordTraded Aug 13 – Aug 27, 2025 · largest single transaction ~$2.03M
Aug 13, 2025~$1.73M · 294K sh @ $5.91
DetailsOfficial recordInsider buying
Traded Jul 23, 2025 · filed 2 days later
Since the trade +60.2% · S&P 500 +8.8% · to Nov 20
A major shareholder of Diamedica Therapeutics paid $10M out of pocket for Diamedica Therapeutics shares. 2 other people at Diamedica Therapeutics bought some too, in the same month. Shares held went up 52% with this purchase.
Insider buying
Traded Jul 23, 2025 · filed 2 days later
Since the trade +60.2% · S&P 500 +8.8% · to Nov 20
A major shareholder of Diamedica Therapeutics paid $5.4M out of pocket for Diamedica Therapeutics shares. 2 other people at Diamedica Therapeutics bought some too, in the same month. Shares held went up 30% with this purchase.
Insider buying
Traded Jul 23, 2025 · filed 2 days later
Since the trade +60.2% · S&P 500 +8.8% · to Nov 20
A major shareholder of Diamedica Therapeutics paid $1.4M out of pocket for Diamedica Therapeutics shares. 2 other people at Diamedica Therapeutics bought some too, in the same month. Shares held went up 9% with this purchase.
Nov 21, 2025~$1.55M · 209K sh @ $7.41
DetailsOfficial recordNov 18, 2025~$1.23M · 183K sh @ $6.75
DetailsOfficial recordNov 17, 2025~$1.22M · 187K sh @ $6.52
DetailsOfficial recordNov 20, 2025~$951K · 128K sh @ $7.41
DetailsOfficial recordNov 25, 2025~$627K · 73K sh @ $8.57
DetailsOfficial recordNov 24, 2025~$318K · 40K sh @ $7.89
DetailsOfficial recordAug 14, 2025~$422K · 70K sh @ $5.99
DetailsOfficial recordAug 20, 2025~$416K · 71K sh @ $5.86
DetailsOfficial recordAug 22, 2025~$357K · 60K sh @ $5.96
DetailsOfficial recordAug 21, 2025~$287K · 48K sh @ $5.96
DetailsOfficial recordAug 25, 2025~$2.03M · 338K sh @ $6.00
DetailsOfficial recordAug 15, 2025~$49K · 8,233 sh @ $6.00
DetailsOfficial recordAug 26, 2025~$358K · 60K sh @ $6.00
DetailsOfficial recordAug 27, 2025~$305K · 51K sh @ $6.00
DetailsOfficial record0 open-market purchases and 0 open-market sales by insiders of DMAC between Mar 1, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 12, 2026.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 12, 2026 | None | None | None |
| Aug 10, 2026 | None | None | None |
| May 6, 2026 | None | None | None |
| Mar 31, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies